Page last updated: 2024-08-17

tetrahydrocortisol and 17-alpha-hydroxyprogesterone

tetrahydrocortisol has been researched along with 17-alpha-hydroxyprogesterone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T	1
Fujimoto, J; Hirose, R; Ichigo, S; Sakaguchi, H; Tamaya, T	1

Reviews

1 review(s) available for tetrahydrocortisol and 17-alpha-hydroxyprogesterone

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000

Other Studies

2 other study(ies) available for tetrahydrocortisol and 17-alpha-hydroxyprogesterone

Article	Year
Sex steroids regulate the expression of plasminogen activator inhibitor-1 and its mRNA in fibroblasts derived from uterine endometrium. Annals of clinical biochemistry, 1996, Volume: 33 ( Pt 6) Topics: 17-alpha-Hydroxyprogesterone; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Fibroblasts; Gonadal Steroid Hormones; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Plasminogen Activator Inhibitor 1; Progesterone; RNA, Messenger; Tetrahydrocortisol	1996
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. Cancer letters, 1999, Jul-01, Volume: 141, Issue:1-2 Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endothelial Growth Factors; Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Lymphokines; Medroxyprogesterone Acetate; Progesterone; Progestins; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydrocortisol; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1999

Article

Year

Sex steroids regulate the expression of plasminogen activator inhibitor-1 and its mRNA in fibroblasts derived from uterine endometrium.

Annals of clinical biochemistry, 1996, Volume: 33 ( Pt 6)

Topics: 17-alpha-Hydroxyprogesterone; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Fibroblasts; Gonadal Steroid Hormones; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Plasminogen Activator Inhibitor 1; Progesterone; RNA, Messenger; Tetrahydrocortisol

1996

Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.

Cancer letters, 1999, Jul-01, Volume: 141, Issue:1-2

Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endothelial Growth Factors; Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Lymphokines; Medroxyprogesterone Acetate; Progesterone; Progestins; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydrocortisol; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1999